| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,132 |
9,129 |
$745K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,069 |
5,577 |
$306K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,457 |
2,421 |
$99K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
4,466 |
4,367 |
$62K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
736 |
733 |
$58K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
532 |
502 |
$43K |
| X5622 |
|
1,068 |
1,041 |
$36K |
| 36415 |
Collection of venous blood by venipuncture |
5,643 |
5,176 |
$22K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
254 |
248 |
$17K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
234 |
220 |
$16K |
| 92551 |
|
1,795 |
1,773 |
$13K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
484 |
460 |
$11K |
| 99188 |
|
735 |
730 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
546 |
533 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
214 |
207 |
$8K |
| 99215 |
Prolong outpt/office vis |
131 |
120 |
$8K |
| 80061 |
Lipid panel |
499 |
488 |
$7K |
| 90686 |
|
1,191 |
1,175 |
$6K |
| 80053 |
Comprehensive metabolic panel |
562 |
546 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
71 |
70 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
226 |
217 |
$4K |
| 90834 |
Psychotherapy, 45 minutes with patient |
45 |
36 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
314 |
298 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
270 |
245 |
$3K |
| 85027 |
|
416 |
386 |
$2K |
| 99173 |
|
1,499 |
1,466 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
268 |
267 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
15 |
15 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
75 |
75 |
$1K |
| 96127 |
|
191 |
189 |
$712.05 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
96 |
92 |
$701.11 |
| 83655 |
|
15 |
15 |
$406.80 |
| 99177 |
|
44 |
44 |
$283.23 |
| 86803 |
|
13 |
13 |
$198.25 |
| 36416 |
|
27 |
27 |
$86.39 |
| 85018 |
|
31 |
29 |
$49.29 |
| 81001 |
|
41 |
37 |
$4.68 |
| 90647 |
|
15 |
15 |
$0.00 |
| 90723 |
|
25 |
25 |
$0.00 |
| 90670 |
|
143 |
142 |
$0.00 |
| 90734 |
|
27 |
27 |
$0.00 |